체외식 페이스메이커 시장 : 기술별, 용도별, 최종 용도별, 예측(2023-2032년)

Global External Pacemaker Market will witness 5% CAGR between 2023 and 2032 due to increased occurrences of cardiovascular diseases and the quest for enhanced treatment devices. Rising heart conditions drive the demand for external pacemakers, crucial in managing cardiac rhythm abnormalities.

For instance, as per the 2023 World Heart Report by the World Heart Federation.org, over 500 million individuals globally grapple with cardiovascular diseases, resulting in approximately 20.5 million deaths in 2021-nearly one-third of all global fatalities and a notable rise from the estimated 121 million CVD-related deaths. Around 4 out of 5 deaths from CVD occur in low- and middle-income nations, while advancements in cardiovascular health predominantly favor high-income countries. This marked health disparity necessitates urgent attention and rectification.

With a growing aging population and lifestyle factors contributing to heart ailments, there's a pressing need for advanced, portable pacemakers. This surge in the external pacemaker market demand reflects the industry's focus on developing innovative devices that offer effective cardiac management, striving to improve patient outcomes and quality of life.

The overall External Pacemaker Market is classified based on application, end-user, and region.

Bradycardia segment will undergo significant development from 2023 to 2032. Bradycardia, a condition marked by an abnormally slow heart rate, prompts the need for external pacemakers to regulate heart rhythm. As this condition affects individuals of varying ages, the market sees a surge in demand for portable, effective pacemakers. The rising incidence of bradycardia underscores the vital role these devices play in managing cardiac abnormalities, driving the external pacemaker market growth from innovative, efficient external pacing solutions.

The external pacemaker market share from the cardiac care centers segment will register a noteworthy CAGR from 2023 to 2032. These centers, dedicated to heart health, rely on external pacemakers for timely intervention in cardiac rhythm irregularities. With a focus on patient care and effective treatment, these facilities drive the market's need for reliable, portable pacemakers. The increasing reliance on these devices within cardiac care centers underscores their critical role in managing cardiac conditions, propelling advancements and innovation within the external pacemaker market share.

Europe external pacemaker industry will showcase a commendable CAGR from 2023 to 2032. With a robust healthcare system emphasizing cardiovascular care, the region drives the need for advanced external pacing solutions. As cardiovascular conditions persist, European healthcare centers prioritize reliable, portable pacemakers. The market's focus on innovation aligns with Europe's commitment to optimizing cardiac care, reflecting the continent's role in steering advancements and adoption of cutting-edge external pacing technologies.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 External pacemaker industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Regional trends
• 2.4 Technology trend
• 2.5 Application trends
• 2.6 End-use trends

Chapter 3 External Pacemaker Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular diseases
    • 3.2.1.2 Favorable reimbursement scenario
    • 3.2.1.3 Growing ageing population
    • 3.2.1.4 Technological advancements
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of the devices
    • 3.2.2.2 Stringent regulatory approvals
• 3.3 Growth potential analysis
  • 3.3.1 By technology
  • 3.3.2 By application
  • 3.3.3 By end-use
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Reimbursement scenario
• 3.7 Technology landscape
• 3.8 Future market trends
• 3.9 Pricing analysis, 2022
• 3.10 Porter's analysis
• 3.11 GAP analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Company market share analysis, 2022
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis
• 4.6 Strategy dashboard, 2022

Chapter 5 External Pacemaker Market Size and Forecast, By Technology (USD Million)

• 5.1 Key technology trends
• 5.2 Single-chamber
• 5.3 Dual-chamber

Chapter 6 External Pacemaker Market Size and Forecast, By Application (USD Million)

• 6.1 Key application trends
• 6.2 Bradycardia
• 6.3 Acute myocardial infarction
• 6.4 Others

Chapter 7 External Pacemaker Market Size and Forecast, By End-use (USD Million)

• 7.1 Key end-use trends
• 7.2 Hospitals
• 7.3 Cardiac care centers
• 7.4 Others

Chapter 8 External Pacemaker Market Size and Forecast, By Region (USD Million)

• 8.1 Key regional trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

• 9.1 Boston Scientific Corporation
• 9.2 Medtronic
• 9.3 Pacetronix
• 9.4 OSYPKA MEDICAL
• 9.5 OSCOR Inc.
• 9.6 Fluke
• 9.7 Abbott
• 9.8 Avery Biomedical Devices, Inc.
• 9.9 BIOTRONIK
• 9.10 Lepu Medical Technology